Background This study proposed to compare the prevalence and risk factors for sarcopenia
by EGWSOP-1 and EWGSOP-2 diagnostic criteria in Iran. Methods This cross-sectional …

Background Although the prevalence of sarcopenic obesity is increasing, nowadays a
universally accepted definition still does not exist. Because, this clinical entity is defined as …

Abstract Background The European Working Group on Sarcopenia in Older People
(EWGSOP) recently updated the definition and diagnostic criteria to assess sarcopenia …

Background: Sarcopenia is defined by the loss of muscle mass and function with a
considerable prevalence which increases morbidity and mortality. We aimed to develop and …

Abstract Background and Purpose The revised European Working Group on Sarcopenia in
Older People (EWGSOP2, version 2019) definition of sarcopenia differs with respect to the …

Aim We aimed to compare diagnostic differences for identification of sarcopenia using the
original operational definition developed by the European Working Group on Sarcopenia in …

Introduction we examined the consequences of applying the new EWGSOP2 algorithm for
sarcopenia screening instead of the former EWGSOP algorithm (EWGSOP1) in geriatric …

Objectives To compare the prevalence and associated factors of sarcopenia defined by the
revised European Working Group on Sarcopenia in Older People (EWGSOP2) criteria with …

Purpose The aim of this study was to determine the prevalence of sarcopenia according to
different methods in older outpatients using regional threshold values of muscle mass and …

Recently the European Working Group on Sarcopenia in Older People (EWGSOP2) has
updated diagnostic criteria for sarcopenia, which consist of one or more measures of muscle …